Headline RoundupSeptember 12th, 2023

FDA Approves New Round of COVID-19 Vaccines

Summary from the AllSides News Team

The United States Food and Drug Administration approved a new round of vaccines against COVID-19.

Key Quotes: According to a statement from the FDA, the new vaccines “more closely target currently circulating variants" and "provide better protection against serious consequences of COVID-19, including hospitalization and death." The FDA is "confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks." The FDA also stated, “​"Barring the emergence of a markedly more virulent variant, the FDA anticipates that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine."

Details: The new vaccines from Moderna and Pfizer-BioNTech have been approved for adults and children 6 months and older. These shots will be the first round of COVID-19 vaccines that are sold commercially by manufacturers and not purchased by the federal government. According to the Wall Street Journal (Center bias), the Moderna vaccine will cost $130 per dose, but many individuals with health insurance will not have to pay out of pocket. 

How the Media Covered It: Outlets across the spectrum reported on the new vaccines in tandem with rising case numbers in the U.S. The Washington Examiner (Lean Right bias) included a quote from WHO COVID-19 Technical Lead Maria Van Kerkhove, who stated last week that data on the vaccine’s effectiveness is "quite limited so far."

Featured Coverage of this Story

More headline roundups

AllSides Picks

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right